ArticleCureus2025
A Beam Orientation Quality Assurance Framework for Gyroscopic Stereotactic Radiosurgery Systems.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Stereotactic radiosurgery using a self-shielded gyroscopic radiosurgery system for meningiomas: technical aspects and dosimetric results.Radiation oncology (London, England) · 2026Article
- A Beam Orientation Quality Assurance Framework for Gyroscopic Stereotactic Radiosurgery Systems.Cureus · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gyroscopic stereotactic radiosurgery (SRS) systems, such as ZAP-X, enable precise, isocentric beam delivery with high conformality and minimal exposure to surrounding tissues. While standard quality assurance (QA) protocols verify beam centricity and overall targeting accuracy, they are not specifically designed to assess the consistency of beam entry angles, which can vary in systems employing gimbaled delivery. These angular variations, though often less consequential at the target, may have significant dosimetric implications for peripheral critical structures. To address this, we developed a practical quality assurance framework using the ArcCHECK cylindrical diode array for periodic beam orientation monitoring. The system comprises 1,386 diodes arranged cylindrically (21 cm diameter), providing a density of 221 diodes per 10×10 cm². Although the array's resolution limits direct dose distribution comparisons, its sensitivity to angular deviations leverages the steep dose fall-off typical in SRS beams. A calibration protocol was established using a 44-beam QA plan with collimators of varying sizes. Sensitivity to beam rotation was quantified as the percentage of diode failures per degree of angular deviation. The 10 mm collimator demonstrated optimal performance, with sensitivity reaching 37.7% per degree, owing to the match between its penumbra and the 1 cm diode spacing. Daily QA measurements confirmed high reproducibility and sensitivity, with a deliberately introduced 0.8° error accurately detected and quantified. This framework, validated through controlled tests, offers a reliable and efficient method to track beam orientation consistency without requiring additional hardware or major workflow changes. While the study serves as a proof of principle within a single institution, broader adoption and multicenter validation could support its standardization. Ultimately, the integration of angular QA enhances treatment fidelity in gyroscopic SRS, ensuring both mechanical precision and patient safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.